BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2025-03-14
• Last 15 days FTD volume: HK$0.02 M
• Last 3 months FTD volume: HK$0.1 M
• Last year FTD volume: HK$0.1 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Repligen RGEN	HK$6.38 M	HK$34.95 M	🇺🇸 USA
Sarepta Therapeutics SRPT	HK$0.5 M	HK$36.16 M	🇺🇸 USA
NanoViricides NNVC	HK$2.23 M	HK$5.86 M	🇺🇸 USA
Novavax NVAX	HK$7.68 M	HK$0.12 B	🇺🇸 USA
Gilead Sciences GILD	HK$10.58 M	HK$97.36 M	🇺🇸 USA
Celldex Therapeutics CLDX	HK$2.66 M	HK$7.11 M	🇺🇸 USA
GlaxoSmithKline GSK	HK$0.18 B	HK$0.27 B	🇬🇧 UK
Emergent BioSolutions EBS	HK$1.19 M	HK$6.21 M	🇺🇸 USA
Cel-Sci CVM	HK$0.38 M	HK$2.52 M	🇺🇸 USA